Q3 2010 · —
Revenue—
Net Income-$4.14M-$4.14M no prior Q3 2009 on fileN/M vs Q2 2010
EPS Diluted-$0.23-$0.23 no prior Q3 2009 on fileN/M vs Q2 2010
Operating Cash Flowderived-$2,237,000—
Free Cash Flowderived-$2,248,000—
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
no prior Q3 2009 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
SELLAS Life Sciences Group, Inc. · CIK 1390478 · Engraved from SEC EDGAR